Hypertension: The rediscovery of combination therapy

Geriatrics

Volumn 52, Issue 11, 1997, Pages 28-38

  Prisant, L Michael ^a   Doll, N Christopher ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL; BENAZEPRIL; BISOPROLOL; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENALAPRIL MALEATE PLUS FELODIPINE; FELODIPINE; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LISINOPRIL; LOSARTAN; UNCLASSIFIED DRUG;

ADULT; AGED; BLOOD PRESSURE MEASUREMENT; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; REVIEW; TITRIMETRY; TREATMENT PLANNING;

AGED; ANTIHYPERTENSIVE AGENTS; DRUG MONITORING; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0031428599     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Prisant LM. Hypertension. In: Conn RB, Borer WZ, Snyder JW (eds). Conn's current diagnosis. Philadelphia: W.B. Saunders, 1997:349-59.
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265(24):3255-64.
3. Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 1997; 278(3):212-6.
4. Burt VL, Culter JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult U.S. population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26(1):60-9.
5. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the U.S. adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25(3):305-13.
6. Wofford JL. History of fixed-dose combination therapy for hypertension. Arch Intern Med 1997; 157(9):1044.
7. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNCV). Arch Intern Med 1993; 153(2):154-83.
8. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 1997; 277(9):739-45.
9. Fagan TC. Remembering the lessons of basic pharmacology. Arch Intern Med 1994; 154(13):1430-1.
10. Fenichel RR, Lipicky RJ. Combination products as first-line pharmacotherapy. Arch Intern Med 1994; 154(13):1429-30.
11. Oster JR, Epstein M. Fixed-dose combination medications for the treatment of hypertension: A critical review. J Clin Hypertens 1987; 3(3):278-93.
12. Morgan TO, Anderson A, Jones E. Comparison and interaction of low dose felodipine and enalapril in the treatment of essential hypertension in elderly subjects. Am J Hypertens 1992; 5:238-43.
13. Kaplan NM. Implications for cost-effectiveness. Combination therapy for systemic hypertension. Am J Cardiol 1995; 76(8):595-7.
14. Fenichel RR, Lipicky RJ. Combination products as first-line pharmacotherapy. Arch Intern Med 1995; 155(1):117.
15. Hash TW, Prisant LM. Beta-blocker use in systolic heart failure and dilated cardiomyopathy. J Clin Pharmacol 1997; 37(1):7-19.
16. Prisant LM, Mensah GA. Use of beta-adrenergic receptor blockers in blacks. J Clin Pharmacol 1996; 36(10):867-73.
17. Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994; 154(13):1461-8.
18. Frishman WH, Burris JF, Mroczek WJ, et al. First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension. J Clin Pharmacol 1995; 35(2):182-8.
19. Neutel JM. Metabolic manifestations of low-dose diuretics. Am J Med 1996; 101(3A):71S-82S.
20. Neutel JM, Black HR, Weber MA. Combination therapy with diuretics: An evo lution of understanding. Am J Med 1996; 101(3A):61S- 70S.
21. Burris JF, Mroczek WJ. A first-line treatment option for elderly hypertensive patients: A low-dose multimechanism β-blocker/diuretic. Am J Geriat Cardiol 1997; 6(1):40-46.
22. Prisant LM, Weir MR, Papademetriou V, et al. Low-dose drug combination therapy: An alternative first-line approach to hypertension treatment. Am Heart J 1995; 130:359-66.
23. DeQuattro V. Comparison of benazepril and other antihypertensive agents alone and in combination with the diuretic hydrochlorothiazide. Clin Cardiol 1991; 14 (suppl IV):28-32.
24. Chrysant SG. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group. Arch Intern Med 1994; 154(7):737-43.
25. Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy. Arch Intern Med 1996; 156(17):1969-78.
26. Frishman WH, Ram CV, McMahon FG, et al. Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: A randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group. J Clin Pharmacol 1995; 35(11):1060-6.
27. Kuschnir E, Acuna E, Sevilla D, et al. Treatment of patients with essential hypertension: Amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo. Clin Ther 1996; 18(6):1213-24.
28. Applegate WB, Cohen JD, Wolfson P, Davis A, Green S. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension. Am J Cardiol 1996; 78(1):51-5.
29. Carr AA, Prisant LM. Losartan: First of a new class of angiotensin antagonists for the management of hypertension. J Clin Pharmacol 1996; 36(1):3-12.
30. Goldberg AI, Dunlay MC, Sweet CS. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol 1995; 75(12):793-5.
31. Pitt B, Segal R, Martinez FA, et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997; 349(9054): 747-52.
32. MacKay JH, Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components. Arch Intern Med 1996; 156(3):278-85.
33. Severs PS, Poulter NR. Calcium antagonists and diuretics as combined therapy. J Hypertens 1987; 5(suppl 4): S123-S126.
34. Chalmers J. The place of combination therapy in the treatment of hypertension in 1993. Clin Exp Hypertens 1993; 15(6):1299-313.
35. Burris JF, Weir MR, Oparil S, Weber M, Cady WJ, Stewart WH. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy. JAMA 1990; 263(11):1507-12.
36. Prisant LM, Carr AA, Nelson EB, Winer N, Velasquez MT, Gonasun LM. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation. Arch Intern Med 1989; 149(11):2453-7.
37. Sutton JM, Bagby SP. Nontraditional combination pharmacotherapy of hypertension. Cleve Clin J Med 1992; 59:459-68.
38. Bursztyn M, Gavras I, Gourley L, DeSilva J, Whalen J, Gavras H. Effect of combination therapy with atenolol and the angiotensin-converting enzyme inhibitor benazepril. Clin Ther 1994; 16(3): 429-36.
39. Brown MJ, Dickerson JE. Alpha-blockade and calcium antagonism: An effective and well-tolerated combination for the treatment of resistant hypertension. J Hypertens 1995; 13(6):701-7.